Unraveling the interactions between environmental factors and genetic polymorphisms in non-Hodgkin lymphoma risk

Expert Review of Anticancer Therapy

Volumn 10, Issue 3, 2010, Pages 403-413

  Wang, Sophia S ^a   Nieters, Alexandra ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Environment; Gene; Interaction; Joint effect; Lymphoma; Non Hodgkin lymphoma

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; ORGANOCHLORINE DERIVATIVE; TUMOR NECROSIS FACTOR INHIBITOR;

AGRICULTURAL WORKER; BIRTH ORDER; BODY MASS; BORRELIA BURGDORFERI; BURKITT LYMPHOMA; CAMPYLOBACTER JEJUNI; CANCER DIAGNOSIS; CANCER RISK; CARCINOGENESIS; CARPENTER; CELIAC DISEASE; CHLAMYDIA; CIGARETTE SMOKING; DISEASE MARKER; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; EPSTEIN BARR VIRUS; FAT INTAKE; GENE EXPRESSION; GENE INTERACTION; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; NONHODGKIN LYMPHOMA; OBESITY; OCCUPATIONAL EXPOSURE; PRINTING; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TEACHER; TOBACCO;

DISEASE SUSCEPTIBILITY; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 77949442041     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.09.194     Document Type: Review

References (71)

1. Last JM. A Dictionary of Epidemiology. Oxford University Press, Oxford, UK (2001).
2. Garcia-Closas M, Malats N, Silverman D et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366(9486), 649-659 (2005).
3. Chatterjee N, Kalaylioglu Z, Moslehi R, Peters U, Wacholder S. Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions. Am. J. Hum. Genet. 79(6), 1002-1016 (2006).
4. Mukherjee B, Ahn J, Gruber SB, Rennert G, Moreno V, Chatterjee N. Tests for gene-environment interaction from case-control data: a novel study of type I error, power and designs. Genet. Epidemiol. 32(7), 615-626 (2008).
5. Mukherjee B, Chatterjee N. Exploiting gene-environment independence for analysis of case-control studies: an empirical Bayes-type shrinkage estimator to trade-off between bias and efficiency. Biometrics 64(3), 685-694 (2008).
6. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107(1), 265-276 (2006).
7. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non- Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann. Hematol. 84(1), 1-12 (2005).
8. Khoury MJ, Wacholder S. Invited commentary: from genome-wide association studies to gene-environmentwide interaction studies - challenges and opportunities. Am. J. Epidemiol. 169(2), 227-230 (2009).
9. Morton LM, Wang SS, Cozen W et al. Etiologic heterogeneity among non- Hodgkin lymphoma subtypes. Blood 112(13), 5150-5160 (2008).
10. Alpen B, Robbecke J, Wundisch T, Stolte M, Neubauer A. Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL). Ann Hematol. 80(Suppl. 3), B106-B107 (2001).
11. Tursi A, Brandimarte G, Torello M. Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C viruspositive patients after anti-hepatitis C virus therapy. J. Clin. Gastroenterol. 38(4), 360-363 (2004).
12. Dohden K, Kaizaki Y, Hosokawa O, Hayashi H, Hattori M. Regression of rectal mucosa-associated lymphoid tissue lymphoma but persistence of Helicobacter pylori infection of gastric mucosa after administration of levofloxacin: report of a case. Dis. Colon Rectum 47(9), 1544-1546 (2004).
13. Landgren O, Albitar M, Ma W et al. B-cell clones as early markers for chronic lymphocytic leukemia. N. Engl. J. Med. 360(7), 659-667 (2009).
14. Marti G, Abbasi F, Raveche E et al. Overview of monoclonal B-cell lymphocytosis. Br. J. Haematol. 139(5), 701-708 (2007).
15. Morton LM, Turner JJ, Cerhan JR et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110(2), 695-708 (2007).
16. Rosenwald A, Staudt LM. Gene expression profiling of diffuse large B-cell lymphoma. Leuk. Lymphoma 44(Suppl. 3), S41-S47 (2003).
17. Rosenwald A, Staudt LM. Clinical translation of gene expression profiling in lymphomas and leukemias. Semin. Oncol. 29(3), 258-263 (2002).
18. Baecklund E, Backlin C, Iliadou A et al. Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis. Arthritis Rheum. 54(12), 3774-3781 (2006).
19. Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1), 275-282 (2004).
20. Choi WW, Weisenburger DD, Greiner TC et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin. Cancer Res. 15(17), 5494-5502 (2009).
21. Pike BL, Greiner TC, Wang X et al. DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia 22(5), 1035-1043 (2008).
22. Chiu BC, Lan Q, Dave BJ, Blair A, Zahm SH, Weisenburger DD. The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma. J. Natl Cancer Inst. Monogr. (39), 69-73 (2008).
23. Chiu BC, Dave BJ, Blair A, Gapstur SM, Zahm SH, Weisenburger DD. Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Blood 108(4), 1363-1369 (2006).
24. Hartge P, Wang S, Bracci PM, Devesa SS, Holly EA. Non Hodgkin lymphoma. In: Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni J Jr (Eds). Oxford University Press, Oxford, UK (2009).
25. Ekstrom SK, Vajdic CM, Falster M et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111(8), 4029-4038 (2008).
26. Vajdic CM, Falster MO, de SS et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res. 69(16), 6482-6489 (2009).
27. Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 16(3), 405-408 (2007).
28. Melbye M, Smedby KE, Lehtinen T et al. Atopy and risk of non-Hodgkin lymphoma. J. Natl. Cancer Inst. 99(2), 158-166 (2007).
29. Hjalgrim H, Engels EA. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J. Intern. Med. 264(6), 537-548 (2008).
30. de SS, Benavente Y, Vajdic CM et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin. Gastroenterol. Hepatol. 6(4), 451-458 (2008).
31. Wang SS, Hartge P. Etiology and epidemiology of non-Hodgkin lymphoma. In: Non-Hodgkin Lymphoma. Mauch PM, Armitage JO, Harris NL, Coiffier B, Dalla-Favera R (Eds). Lippincott, Williams and Wilkins, PA, USA (2010).
32. Hoffman AE, Zheng T, Stevens RG et al. Clock-cancer connection in non- Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res. 69(8), 3605-3613 (2009).
33. Purdue MP, Severson RK, Colt JS et al. Degreasing and risk of non-Hodgkin lymphoma. Occup. Environ. Med. 66(8), 557-560 (2009).
34. Wang R, Zhang Y, Lan Q et al. Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am. J. Epidemiol. 169(2), 176-185 (2009).
35. Kricker A, Armstrong BK, Hughes AM et al. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int. J. Cancer 122(1), 144-154 (2008).
36. Morton LM, Zheng T, Holford TR et al. Alcohol consumption and risk of non- Hodgkin lymphoma: a pooled analysis. Lancet Oncol. 6(7), 469-476 (2005).
37. Lu Y, Prescott J, Sullivan-Halley J et al. Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California teachers study. Am. J. Epidemiol. 170(10), 1231-1240 (2009).
38. Kelemen LE, Wang SS, Lim U et al. Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk. Cancer Causes Control 19(5), 491-503 (2008).
39. Willett EV, Morton LM, Hartge P et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int. J. Cancer 122(9), 2062-2070 (2008).
40. Purdue MP, Bassani DG, Klar NS, Sloan M, Kreiger N. Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: a case-control analysis. Cancer Epidemiol. Biomarkers Prev. 13(10), 1665-1676 (2004).
41. Morton LM, Hartge P, Holford TR et al. Cigarette smoking and risk of non- Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Cancer Epidemiol. Biomarkers Prev. 14(4), 925-933 (2005)
42. Zhang Y, Sanjose SD, Bracci PM et al. Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am. J. Epidemiol. 167(11), 1321-1331 (2008).
43. Karlson EW, Chibnik LB, Tworoger SS et al. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum. 60(3), 641-652 (2009).
44. Grulich AE, Wan X, Law MG et al. B-cell stimulation and prolonged immune deficiency are risk factors for non- Hodgkin's lymphoma in people with AIDS. AIDS 14(2), 133-140 (2000).
45. Engels EA, Chatterjee N, Cerhan JR et al. Hepatitis C virus infection and non- Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int. J. Cancer 111(1), 76-80 (2004).
46. Waterland RA. Is epigenetics an important link between early life events and adult disease? Horm. Res. 71(Suppl. 1), 13-16 (2009).
47. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 359(1), 61-73 (2008).
48. Skibola CF, Curry JD, Nieters A. Genetic susceptibility to lymphoma. Haematologica 92(7), 960-969 (2007).
49. Wang SS, Cerhan JR, Hartge P et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res. 66(19), 9771-9780 (2006).
50. Rothman N, Skibola CF, Wang SS et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol. 7(1), 27-38 (2006).
51. Skibola CF, Bracci PM, Halperin E et al. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat. Genet. 41(8), 873-875 (2009).
52. Di Bernardo MC, Crowther-Swanepoel D, Broderick P et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat. Genet. 40(10), 1204-1210 (2008).
53. Wang SS, Cozen W, Cerhan JR et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res. 67(10), 5042-5054 (2007).
54. Colt JS, Rothman N, Severson RK et al. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood 113(9), 1899-1905 (2009).
55. Han J, Kraft P, Nan H et al. A genomewide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 4(5), e1000074 (2008).
56. Wang SS, Purdue MP, Cerhan JR et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS ONE 4(4), e5360 (2009).
57. Gathany AH, Hartge P, Davis S et al. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma. Cancer Causes Control 20(8), 1291-1302 (2009).
58. Morton LM, Schenk M, Hein DW et al. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma. Pharmacogenet. Genomics 16(8), 537-545 (2006).
59. Lim U, Wang SS, Hartge P et al. Gene- nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCISEER case-control study. Blood 109(7), 3050-3059 (2007).
60. Purdue MP, Hartge P, Davis S et al. Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control 18(9), 989-999 (2007).
61. Morton LM, Bernstein L, Wang SS et al. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis 28(8), 1759-1764 (2007).
62. Wild CP. Environmental exposure measurement in cancer epidemiology. Mutagenesis 24(2), 117-125 (2009).
63. Besson C, Amiel C, Le-Pendeven C et al. Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas. J. Infect. Dis. 199(8), 1121-1127 (2009).
64. Gao L, Weck MN, Michel A, Pawlita M, Brenner H. Association between chronic atrophic gastritis and serum antibodies to
65. Helicobacter pylori proteins measured by multiplex serology. Cancer Res. 69(7), 2973-2980 (2009).
66. Gao L, Michel A, Weck MN, Arndt V, Pawlita M, Brenner H. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res. 69(15), 6164-6170 (2009).
67. Hoeft B, Becker N, Deeg E, Beckmann L, Nieters A. Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma. Cancer Causes Control 19(2), 163-173 (2008).
68. Willett EV, Skibola CF, Adamson P et al. Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms. Br. J. Cancer 93(7), 811-816 (2005).
69. Skibola CF, Holly EA, Forrest MS et al. Body mass index, leptin and leptin receptor polymorphisms, and non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 13(5), 779-786 (2004).
70. Han X, Zheng T, Lan Q et al. Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 18(5), 1429-1438 (2009).
71. Kilfoy BA, Zheng T, Lan Q et al. Genetic polymorphisms in glutathione S-transferases and cytochrome P450s, tobacco smoking, and risk of non-Hodgkin lymphoma. Am. J. Hematol. 84(5), 279-282 (2009).